Evaluation of Neurological and Auditory Development in Children with Congenital Heart Disease using Essence Q Questionnaire and Auditory Brainstem Response (ABR) Test neurological ,auditory development in congenital heart disease
Iranian Journal of Child Neurology,
Vol. 18 No. 1 (2024),
18 Dey 2024
,
Page 43-50
https://doi.org/10.22037/ijcn.v18i1.39186
Abstract
Objectives
The progress of cardiac surgery in children and the increase in the survival of children with Congenital Heart Disease (CHD) has led to consider another issue called a neurodevelopmental disorder. In this study, 53 children with CHD were evaluated in terms of development with the Essence Q questionnaire, Otoacoustic Emission (OAE), and Auditory Brainstem Response (ABR) regarding these patients’ hearing and risk factors. The Essence Q scores were also examined
Materials & Methods
In this prospective, cross-sectional study, the researchers included 53 children diagnosed with CHD. Initially, each child underwent ABR and OAE tests. Subsequently, data on potential risk factors
associated with neurodevelopmental delay were collected. A trained project associate administered the Essence Q questionnaire, using parents’ information as a guide. Following data collection, this study proceeded with an in-depth analysis of the information.
Results
Thirty-six boys (67.92%) and 17 girls (32.08%) with CHD were included in the study. The mean age of children was 2/23+_8.11. The mean Essence Q score for boys was 7.48+_2.57.
Moreover, the average score for girls was 2.23 8.11. According to this questionnaire, 39 patients (73.58%) had hyperactivity disorder,46 patients (86.79%) had behavioral disorders, and ten patients (16.98%) had a motor delay. Unlike previous studies, all patients had normal OAE and ABR hearing.
Conclusion
This study demonstrated that factors such as developmental delay in the first year, a known genetic disease, and a history of seizures significantly impacted the Essence Q score. However, elements like prematurity, the use of ventilation, abnormalities on the dorsum, and the number of days post surgery did not significantly affect the Essence Q score. Essence Q can be a reliable tool in screening for neurodevelopment in children with CHD
- congenital heart disease, neurodevelopmental delay, ESSENCE Q questioner, Auditory Brainstem evokes potential (ABR)
How to Cite
References
2-Mussatto KA, Hoffmann RG, Hoffman GM, et al. Risk and prevalence of developmental delay in young children with congenital heart disease. Pediatrics. 2014:3570–e577.
3 - Ballweg JA 1 , Wernovsky G, Gaynor JW Neurodevelopmental outcomes following congenital heart surgery Pediatr Cardiol . Mar-Apr 2007;28(2):126-33. doi: 10.1007/s00246-006-1450-9. •
4- Marelli A , Miller SP , Marino BS , Jefferson A L , Newburger J W ''Brain in Congenital Heart Disease Across the Lifespan: The Cumulative Burden of Injury'' Circulation 2016 May 17;133(20):1951-62. doi: 10.1161/CIRCULATIONAHA.115.019881
5-Patricia O’Brien, Developmental Disabilities Create Academic Challenges for Kids with Complex CHD
6-Limperopoulos C, Tworetzky W, McElhinney DB, Newburger JW, Brown DW, Robertson RL, Guizard N, McGrath E, Geva J, Annese D, Dunbar-Masterson C, Trainor B, Laussen PC, du Plessis AJ.Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and ectroscopy.Circulation. 2010; 121:26–33. doi: 10.1161/CIRCULATIONAHA.109.865568
7-.Licht DJ, Shera DM, Clancy RR, Wernovsky G, Montenegro LM, Nicolson SC, Zimmerman RA, Spray TL, Gaynor JW, Vossough A.Brain maturation is delayed in infants with complex congenital heart defects.J Thorac Cardiovasc Surg. 2009; 137:529–536.
8- Wernovsky G and Licht D J ''Neurodevelopmental Outcomes in Children with Congenital Heart Disease – What can we impact?'' Pediatr Crit Care Med. 2016 Aug; 17(8 Suppl 1): S232–S242. doi: 10.1097/PCC.0000000000000800
9-Lalitha Gopineti , Mane Paulpillai, Andrea Rosenquist, Andrew H. Van Bergen ''Prevalence of Sensorineural Hearing Loss in Children with Palliated or Repaired Congenital Heart Disease ''Cureus 12(1): e6566. doi:10.7759/cureus.6566
10-- KA Mussatto, R Hoffmann, G Hoffman, JS Twedde ‘’Risk Factors for Abnormal Developmental Trajectories in Young Children with Congenital Heart Disease’’ Circulation, 2015 -August 25 Vol 132, Issue 8
11-Gilberg C' The ESSENCE in child psychiatry: Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations' Research in Developmental Disabilities 2010' http://dx.doi.org/10.1016/j.ridd.2010.06.002
12- . White B R, ,a Rogers L S, and Kirschen P M ‘’Recent Advances in Our Understanding of Neurodevelopmental Outcomes in Congenital Heart Disease”Curr Opin Pediatr .2019.31(6):783-788
13-Hatakenaka Y,Fernell E,Sokaguchi M,Ninomiya H,Fukunaga I’’ ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan’’ Neuropsychiatr Dis Treat. 2016; 12: 1739–1746
14- Taylor K, Well A , Mercado A, Reilly S, Whipple H et al '' Abstract 10260: Risk Factors for Developmental Delay in Congenital Heart Disease Patients Following Surgery'Circulation. 2021;144:A10260'
15- Beena Johnson ''Behaviour Problems in Children with Congenital Heart Disease'' BMH Medical Journal 2015;2(1):14-19 '
- Abstract Viewed: 74 times